Drugs for life how pharmaceutical companies define our health
Material type:
TextSeries: Experimental futuresPublication details: Durham Duke University Press 2012Description: xii,262pISBN: - 9780822348603
- 338.4761510973 23 DU-D
- HD9666.5 .D86 2012
Print
| Item type | Home library | Collection | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
|
Print
|
OPJGU Sonepat- Campus Main Library | General Books | 338.4761510973 DU-D (Browse shelf(Opens below)) | Available | 123801 |
Browsing OPJGU Sonepat- Campus shelves, Collection: General Books Close shelf browser (Hides shelf browser)
|
|
|
|
|
|
|
||
| 338.4760973 GR-S Silicon states the power and politics of big tech and what it means for our future / | 338.4761486 CA-C Cost of accidents a legal and economic analysis | 338.476151 RA-B Biocapital the constitution of postgenomic life | 338.4761510973 DU-D Drugs for life how pharmaceutical companies define our health | 338.4761510973 EP-O Overdose how excessive government regulation stifles pharmaceutical innovation | 338.476205 NE- New global frontiers in regulation the age of nanotechnology | 338.47621 MI-E Electronic business |
Includes bibliographical references and index.
Responding to facts -- Pharmaceutical witnessing and direct-to-consumer advertising -- Having to grow medicine -- Mass health : illness is a line you cross -- Moving the lines : deciding on thresholds -- Knowing your numbers : pharmaceutical lifestyles.
There are no comments on this title.